Pre-ICH warfarin use, not antiplatelets, increased case fatality in spontaneous ICH patients

Y. W. Chen, S. C. Tang, L. K. Tsai, S. J. Yeh, H. Y. Chiou, P. K. Yip, J. S. Jeng

研究成果: 雜誌貢獻文章

13 引文 斯高帕斯(Scopus)

摘要

Background and purpose: Anticoagulant and antiplatelets for prevention of ischaemic stroke and cardiovascular diseases may increase the risk of intracerebral hemorrhage (ICH). This study aimed to investigate the influence of pre-ICH use of anticoagulant and antiplatelets on ICH patients. Methods: Consecutive patients with acute spontaneous ICH registered in a single-center stroke registry during 2001 to 2010 were analyzed and categorized according to their pre-ICH use of warfarin (Group I), antiplatelets (Group II), or neither (Group III). Survival analysis and the Cox proportional hazard model were used to compare between the three groups and the predictors. Results: Of 2021 ICH patients (male, 63.3%; mean age, 62.6 ± 14.4 years) included, there were 94 (4.7%) in Group I, 232 (11.4%) in Group II, and 1695 (83.9%) in Group III. Warfarin users had larger hematoma volume, more intraventricular extension, higher frequencies of lobar ICH, and higher case fatality than non-warfarin users (Groups II and III). The Cox proportional hazard model showed increased 6-month case fatality in pre-ICH warfarin users (adjusted hazard ratio 2.75, 95% confidence interval 2.04-3.72, P 

原文英語
頁(從 - 到)1128-1134
頁數7
期刊European Journal of Neurology
20
發行號8
DOIs
出版狀態已發佈 - 八月 2013

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

指紋 深入研究「Pre-ICH warfarin use, not antiplatelets, increased case fatality in spontaneous ICH patients」主題。共同形成了獨特的指紋。

  • 引用此